Hongqi Pharmaceutical
HONGQI PHARMACEUTICAL
Cherish life, pay attention to health.
CHERISH LIFE CARE ABOUT HEALTH
China's largest pharmaceutical industry event: news from the front of Kunming Pharmaceutical Fair!
Category:
Trade info
Author:
Source:
Add time:2016-12-05 21:55
From December 2 to December 4, 2016, as the largest pharmaceutical industry event in China—the 76th National Pharmaceutical Fair was held in Kunming Dianchi International Convention and Exhibition Center, Fosun Pharmaceutical Group brought many core Pharmaceutical and diagnostics member companies participated in the exhibition, which concentratedly demonstrated Fosun Pharma's innovative R&D capabilities and branded products.
The National Pharmaceutical Fair is a trade fair for pharmaceutical preparations, health products and related technologies and services with a long history in China. The exhibition area of this grand event exceeded 80,000 square meters, and more than 2,000 pharmaceutical companies participated in the exhibition, attracting more than 120,000 dealers and agents from all over the country.
In recent years, Fosun Pharma has continued to increase R&D investment, and has formed an international R&D layout and strong R&D capabilities. At present, Fosun Pharma Group has nearly 900 R&D personnel. Through its layout in Shanghai, Chongqing, Taipei, and San Francisco, the United States has established an interactive and integrated R&D system, and has continuously increased investment in the four major R&D platforms. The fields of macromolecular biosimilar drugs, high-value generic drugs, and specialty preparation technologies have created an efficient R&D platform.
Fosun Pharma has a total of 7 pharmaceutical member companies participating in the exhibition, including Yaoyou Pharmaceutical, Wanbang Pharmaceutical, Guilin Pharmaceutical, Aohong Pharmaceutical, Dongting Pharmaceutical, Hongqi Pharmaceutical, Erye Pharmaceutical, and the products on display cover metabolic and Digestive system, cardiovascular system, blood system, central nervous system, anti-infection, anti-tumor and other fields. Among them, Yaoyou Pharmaceutical pioneered the world’s first nanoemulsion freeze-drying technology, and the technology application product—alprostadil dry emulsion for injection has been widely recognized in the market; Wanbang Pharmaceutical’s diabetes drug business scale is in a leading position in China; Febuxostat tablets) and Wansuping (glimepiride tablets) have a leading domestic market share; Compound Aloe Capsules, Xiaokekang Granules, Xihuang Capsules, and Dunye Guanxinning Tablets are exclusive varieties; Adenosine meglumine injection series), Keyuan (calcium dobesilate capsules), Cestbon (EPO) and other products rank among the best in the domestic market; Guilin Pharmaceutical is China’s largest original research enterprise of artemisinin drugs, and also At present, the only domestic preparation product has passed the World Health Organization pre-certified antimalarial drug supplier, especially its innovative drug Artesun for injection with independent intellectual property rights, which has been successfully introduced to the international market and is an artemisinin antimalarial drug Aohong Pharmaceutical is a high-tech biopharmaceutical company that develops and produces and sells biochemical drugs. Among them, Aodejin (calf serum deproteinized injection) and Bangting (homoray venom hemagglutination for injection) Enzymes) are the company’s star products; Dongting Pharmaceutical is a leading enterprise in the field of psychiatric drugs and chemical hemostatic drugs. One of its leading products is quetiapine fumarate, which is an atypical antipsychotic drug. The first-line clinical drugs have a market share in the forefront of the country; Hongqi Pharmaceuticals is the designated manufacturer of the Ministry of Health's "TB Control Project", an anti-tuberculosis drug manufacturer recommended to the world by the WHO, and China's largest anti-tuberculosis drug R&D and production base. The sales of its first-line tuberculosis drugs and FDC (fixed-dose combination) products have always been in the forefront of the country, such as ethampyrazine, rifampicin tablets (Ⅱ), and Yifu capsules/tablets; Erye Pharmaceuticals is committed to becoming a global anti-infective drug professional Manufacturers and service providers provide system solutions for the fight against infectious diseases. The comprehensive and sophisticated antibiotic product structure is its biggest product highlight.
In addition, in terms of diagnostic reagents, Fosun Pharma began to specialize in diversified operations in the field of in vitro diagnostics earlier in China, and its products involve clinical chemistry, clinical immunology, molecular diagnostics (including gene chip technology), clinical microbiology and other laboratory medicines. It has become one of the most independent research and development and production of in vitro diagnostic products in China. It currently owns advantageous brands such as "Long March" and "Yaneng".
Continue to innovate and enjoy health. Facing the future, Fosun Pharmaceutical Group will continue to promote human health as its mission, adopt a strategic development model of “endogenous growth, extensional expansion and integrated development”, and devote itself to recreating the research and development of the health industry through innovation and integration. , Production, operation, circulation and service system to provide more efficient, better quality and more convenient products and services.
